Covered recipient · General Payments record
BALIN A DURR
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2023
$2,943.31
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $578.40 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $284.75 | 5 |
| ABBVIE INC. | $273.48 | 12 |
| Otsuka America Pharmaceutical, Inc. | $20.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $85.46 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771841 | CMS |
| AbbVie Inc. | $7.32 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771847 | CMS |
| AbbVie Inc. | $3.22 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771851 | CMS |
| AbbVie Inc. | $4.94 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771855 | CMS |
| AbbVie Inc. | $9.61 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771861 | CMS |
| AbbVie Inc. | $9.44 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771865 | CMS |
| AbbVie Inc. | $113.72 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771871 | CMS |
| AbbVie Inc. | $7.14 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771875 | CMS |
| AbbVie Inc. | $3.91 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771881 | CMS |
| AbbVie Inc. | $8.06 | 08/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771885 | CMS |
| AbbVie Inc. | $9.42 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771891 | CMS |
| AbbVie Inc. | $11.24 | 09/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996771895 | CMS |
| Janssen Pharmaceuticals, Inc | $113.88 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987812663 | CMS |
| Janssen Pharmaceuticals, Inc | $30.00 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987812675 | CMS |
| Janssen Pharmaceuticals, Inc | $79.64 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987812669 | CMS |
| Janssen Pharmaceuticals, Inc | $28.17 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987812651 | CMS |
| Janssen Pharmaceuticals, Inc | $33.06 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987812657 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.17 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014319453 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.